Chemical Trade with the United States in 2016

| February 1, 2018

article image
Chemicals used to produce raw materials or intermediate inputs for other industries. Chemicals used to manufacture consumer products and other goods. Wholesale, retail and service industries based on chemistry derived products.

Spotlight

Cybrexa Therapeutics

Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach will change the paradigm of drug delivery, and it will greatly enhance the therapeutic index. It has the potential to re-define the definition of “drug-like,” which will unlock a vast array of molecules for clinical development. Our collection of tumor-localizing DNA repair inhibitors can be combined with numerous chemotherapies and also radiotherapy, allowing the safe delivery of higher drug doses, with enhanced efficacy.

OTHER ARTICLES

Reimagining the Workforce with Anglo American

Article | June 21, 2021

“At Anglo-American, we’re really focused on finding the best ways to attract the most talented people in the industry and effectively equipping our existing workforce based on what they need today and what the future will mean for their careers. We’re also committed to providing learning opportunities that lead to growth and development in the communities in which we operate. Our people are a strategic advantage. We want to ensure that continues to be the case as the mining industry evolves and faces more disruption.

Read More

Transforming Recycled Plastic into Additives for Industrial and Consumer Products

Article | March 24, 2020

With a more increased focus on adding more recycled content to products, it’s becoming very apparent that innovation is required in order to meet these demands. During the Plastics Recycling Conference, Canadian cleantech company GreenMantra Technologies accepted the Association of Plastics Recyclers (APR) Showcase Award, which is given to companies who have a innovative and potentially game-changing idea to advance the recycling of plastics. GreenMantra Technologies is a clean technology company that utilizes a proprietary catalyst and patented depolymerization process to upcycle and transform recycled plastics into value-added synthetic waxes and specialty polymers.

Read More

CHEMICAL SPILL PREVENTION

Article | February 28, 2020

When it comes to your workplace, nothing should be prioritized over the safety of your employees. As your greatest asset to your business, they should feel safe in their work environment. Maintaining a safe work environment is a particularly important consideration for companies who work with or store hazardous materials. And it is not only critical for the appeasement of the Occupational Health and Safety Administration (OSHA) and the Environmental Protection Agency (EPA) requirements but the well-being and safety of your employees. That’s why, in this article, we will discuss chemical spill prevention in your workplace facility.

Read More

Guyana-Suriname basin: Rise from obscurity to super potential

Article | May 13, 2021

Recent discoveries in the Guyana-Suriname basin attest to estimates of 10+ Bbbl of oil resources and more than 30 Tcf of gas.1 Like many oil & gas successes, this is a story that begins with early exploration success onshore, followed by a long period of exploration disappointment in coastal to shelf regions offshore, eventually culminating in deepwater success.

Read More

Spotlight

Cybrexa Therapeutics

Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach will change the paradigm of drug delivery, and it will greatly enhance the therapeutic index. It has the potential to re-define the definition of “drug-like,” which will unlock a vast array of molecules for clinical development. Our collection of tumor-localizing DNA repair inhibitors can be combined with numerous chemotherapies and also radiotherapy, allowing the safe delivery of higher drug doses, with enhanced efficacy.

Events